Skip to main content
Erschienen in:

02.02.2022 | COVID-19 Zur Zeit gratis

Support for COVID-19-Related Substance Use Services Policy Changes: a New York State-Wide Survey

verfasst von: Amar D. Mandavia, MA, Aimee Campbell, PhD., Brandy F. Henry, PhD., Michael Chaple, PhD., Timothy Hunt, PhD., Caroline Arout, PhD., Elwin Wu, PhD., Harold A. Pincus, MD, Edward V. Nunes, MD, Pat Lincourt, MSW, Frances R. Levin, MD, Nabila El-Bassel, PhD.

Erschienen in: The Journal of Behavioral Health Services & Research | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

This study aims to describe which substance use service (SUS) organizations and who within these organizations support the maintenance of policies targeted at improving substance use treatment services. An online survey assessing respondent, organizational and program demographics, and knowledge and support regarding policy changes was distributed to all certified SUS and harm reduction programs in NYS. Bivariate and latent class analyses were used to identify patterns and associations to policy choices. Across the 227 respondents, there was a support for maintaining expansion of insurance coverage, virtual behavioral health/counseling and medication initiation/maintenance visits, reductions in prior authorizations, and access to prevention/harm reduction services. Three classes of support for policies were derived: (1) high-supporters (n = 49; 21%), (2) low-supporters (n = 66; 29%), and (3) selective-supporters. Having knowledge of policy changes was associated with membership in the high-supporters class. Implications regarding the role of knowledge in behavioral health policies dissemination structures, decision-making, and long-term expansion of SUS are discussed.
Literatur
1.
Zurück zum Zitat Center LA. Evidence Based Strategies for Abatement of Harms from the Opioid Epidemic. Cambridge, MA: Harvard Medical School, Blavatnik Institute for Health Care Policy, 2020. Center LA. Evidence Based Strategies for Abatement of Harms from the Opioid Epidemic. Cambridge, MA: Harvard Medical School, Blavatnik Institute for Health Care Policy, 2020.
2.
Zurück zum Zitat American Society of Addiction Medicine Board of Directors. Public Policy Statement on Advancing Racial Justice in Addiction Medicine. Rockville, MD: American Society of Addiction Medicine, 2021. American Society of Addiction Medicine Board of Directors. Public Policy Statement on Advancing Racial Justice in Addiction Medicine. Rockville, MD: American Society of Addiction Medicine, 2021.
3.
Zurück zum Zitat Marlatt GA. Harm reduction: Come as you are. Addictive Behaviors. 1996;21(6):779-788.CrossRef Marlatt GA. Harm reduction: Come as you are. Addictive Behaviors. 1996;21(6):779-788.CrossRef
4.
Zurück zum Zitat Damschroder LJ, Aron DC, Keith RE, et al. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implementation Science. 2009;4(1):1-15.CrossRef Damschroder LJ, Aron DC, Keith RE, et al. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implementation Science. 2009;4(1):1-15.CrossRef
5.
Zurück zum Zitat Rogers EM. A prospective and retrospective look at the diffusion model. Journal of Health Communication. 2004;9(S1):13-19.CrossRef Rogers EM. A prospective and retrospective look at the diffusion model. Journal of Health Communication. 2004;9(S1):13-19.CrossRef
6.
Zurück zum Zitat Purtle J, Lê-Scherban F, Shattuck P, et al. An audience research study to disseminate evidence about comprehensive state mental health parity legislation to US State policymakers: protocol. Implementation Science. 2017;12(1):1-13.CrossRef Purtle J, Lê-Scherban F, Shattuck P, et al. An audience research study to disseminate evidence about comprehensive state mental health parity legislation to US State policymakers: protocol. Implementation Science. 2017;12(1):1-13.CrossRef
7.
Zurück zum Zitat Rogers EM. Diffusion of Innovations: modifications of a model for telecommunications. Die diffusion von innovationen in der telekommunikation: Springer; 1995:25–38. Rogers EM. Diffusion of Innovations: modifications of a model for telecommunications. Die diffusion von innovationen in der telekommunikation: Springer; 1995:25–38.
8.
Zurück zum Zitat Rogers EM, Williams D. Diffusion of. Innovations. Glencoe, IL: The Free Press, 1962. Rogers EM, Williams D. Diffusion of. Innovations. Glencoe, IL: The Free Press, 1962.
9.
Zurück zum Zitat Knudsen HK, Abraham AJ, Oser CB. Barriers to the implementation of medication-assisted treatment for substance use disorders: The importance of funding policies and medical infrastructure. Evaluation and Program Planning. 2011;34(4):375-381.CrossRef Knudsen HK, Abraham AJ, Oser CB. Barriers to the implementation of medication-assisted treatment for substance use disorders: The importance of funding policies and medical infrastructure. Evaluation and Program Planning. 2011;34(4):375-381.CrossRef
10.
Zurück zum Zitat Heinrich CJ, Cummings GR. Adoption and diffusion of evidence‐based addiction medications in substance abuse treatment. Health Services Research. 2014;49(1):127-152.CrossRef Heinrich CJ, Cummings GR. Adoption and diffusion of evidence‐based addiction medications in substance abuse treatment. Health Services Research. 2014;49(1):127-152.CrossRef
11.
Zurück zum Zitat Gotham HJ. Diffusion of mental health and substance abuse treatments: Development, dissemination, and implementation. Clinical Psychology: Science and Practice. 2004;11(2):160-176. Gotham HJ. Diffusion of mental health and substance abuse treatments: Development, dissemination, and implementation. Clinical Psychology: Science and Practice. 2004;11(2):160-176.
12.
Zurück zum Zitat Bride BE, Abraham AJ, Roman PM. Organizational factors associated with the use of contingency management in publicly funded substance abuse treatment centers. Journal of Substance Abuse Treatment. 2011;40(1):87-94.CrossRef Bride BE, Abraham AJ, Roman PM. Organizational factors associated with the use of contingency management in publicly funded substance abuse treatment centers. Journal of Substance Abuse Treatment. 2011;40(1):87-94.CrossRef
13.
Zurück zum Zitat Zhou M, Thayer WM, Bridges JF. Using latent class analysis to model preference heterogeneity in health: a systematic review. Pharmacoeconomics. 2018;36(2):175-187.CrossRef Zhou M, Thayer WM, Bridges JF. Using latent class analysis to model preference heterogeneity in health: a systematic review. Pharmacoeconomics. 2018;36(2):175-187.CrossRef
14.
Zurück zum Zitat Yano EM. The role of organizational research in implementing evidence-based practice: QUERI Series. Implementation Science. 2008;3(1):1-15.CrossRef Yano EM. The role of organizational research in implementing evidence-based practice: QUERI Series. Implementation Science. 2008;3(1):1-15.CrossRef
15.
Zurück zum Zitat Nylund KL, Asparouhov T, Muthén BO. Deciding on the number of classes in latent class analysis and growth mixture modeling: A Monte Carlo simulation study. Structural Equation Modeling: A Multidisciplinary Journal. 2007;14(4):535-569.CrossRef Nylund KL, Asparouhov T, Muthén BO. Deciding on the number of classes in latent class analysis and growth mixture modeling: A Monte Carlo simulation study. Structural Equation Modeling: A Multidisciplinary Journal. 2007;14(4):535-569.CrossRef
16.
Zurück zum Zitat Nylund-Gibson K, Choi AY. Ten frequently asked questions about latent class analysis. Translational Issues in Psychological Science. 2018;4(4):440.CrossRef Nylund-Gibson K, Choi AY. Ten frequently asked questions about latent class analysis. Translational Issues in Psychological Science. 2018;4(4):440.CrossRef
17.
Zurück zum Zitat IBM SPSS Statistics for Windows [computer program]. Version 27. Released 2020. IBM SPSS Statistics for Windows [computer program]. Version 27. Released 2020.
18.
Zurück zum Zitat Feder KA, Krawczyk N, Mojtabai R, et al. Health insurance coverage is associated with access to substance use treatment among individuals with injection drug use: Evidence from a 12-year prospective study. Journal of Substance Abuse Treatment. 2019;96:75-81.CrossRef Feder KA, Krawczyk N, Mojtabai R, et al. Health insurance coverage is associated with access to substance use treatment among individuals with injection drug use: Evidence from a 12-year prospective study. Journal of Substance Abuse Treatment. 2019;96:75-81.CrossRef
19.
Zurück zum Zitat Zheng W, Nickasch M, Lander L, et al. Treatment outcome comparison between telepsychiatry and face-to-face buprenorphine medication-assisted treatment (MAT) for opioid use disorder: A 2-year retrospective data analysis. Journal of Addiction Medicine. 2017;11(2):138.CrossRef Zheng W, Nickasch M, Lander L, et al. Treatment outcome comparison between telepsychiatry and face-to-face buprenorphine medication-assisted treatment (MAT) for opioid use disorder: A 2-year retrospective data analysis. Journal of Addiction Medicine. 2017;11(2):138.CrossRef
20.
Zurück zum Zitat Madden EF. Intervention stigma: How medication-assisted treatment marginalizes patients and providers. Social Science & Medicine. 2019;232:324-331.CrossRef Madden EF. Intervention stigma: How medication-assisted treatment marginalizes patients and providers. Social Science & Medicine. 2019;232:324-331.CrossRef
21.
Zurück zum Zitat Wilkinson R, Hines L, Holland A, et al. Rapid evidence review of harm reduction interventions and messaging for people who inject drugs during pandemic events: implications for the ongoing COVID-19 response. Harm Rreduction Journal. 2020;17(1):1-10.CrossRef Wilkinson R, Hines L, Holland A, et al. Rapid evidence review of harm reduction interventions and messaging for people who inject drugs during pandemic events: implications for the ongoing COVID-19 response. Harm Rreduction Journal. 2020;17(1):1-10.CrossRef
22.
Zurück zum Zitat Tucker JS, D'Amico EJ, Pedersen ER, et al. Behavioral health and service usage during the COVID-19 pandemic among emerging adults currently or recently experiencing homelessness. Journal of Adolescent Health. 2020;67(4):603-605.CrossRef Tucker JS, D'Amico EJ, Pedersen ER, et al. Behavioral health and service usage during the COVID-19 pandemic among emerging adults currently or recently experiencing homelessness. Journal of Adolescent Health. 2020;67(4):603-605.CrossRef
23.
Zurück zum Zitat Gagnon ML. Moving knowledge to action through dissemination and exchange. Journal of Clinical Epidemiology. 2011;64(1):25-31.CrossRef Gagnon ML. Moving knowledge to action through dissemination and exchange. Journal of Clinical Epidemiology. 2011;64(1):25-31.CrossRef
24.
Zurück zum Zitat Dobbins M, Ciliska D, Cockerill R, et al. A framework for the dissemination and utilization of research for health‐care policy and practice. Worldviews on Evidence‐based Nursing presents the archives of Online Journal of Knowledge Synthesis for Nursing. 2002;9(1):149-160. Dobbins M, Ciliska D, Cockerill R, et al. A framework for the dissemination and utilization of research for health‐care policy and practice. Worldviews on Evidence‐based Nursing presents the archives of Online Journal of Knowledge Synthesis for Nursing. 2002;9(1):149-160.
25.
Zurück zum Zitat Straus SE, Tetroe JM, Graham ID. Knowledge translation is the use of knowledge in health care decision making. Journal of Clinical Epidemiology. 2011;64(1):6-10.CrossRef Straus SE, Tetroe JM, Graham ID. Knowledge translation is the use of knowledge in health care decision making. Journal of Clinical Epidemiology. 2011;64(1):6-10.CrossRef
26.
Zurück zum Zitat Needham C. Personalization: From story‐line to practice. Social Policy & Administration. 2011;45(1):54-68.CrossRef Needham C. Personalization: From story‐line to practice. Social Policy & Administration. 2011;45(1):54-68.CrossRef
27.
Zurück zum Zitat Zhou S, Niederdeppe J. The promises and pitfalls of personalization in narratives to promote social change. Communication Monographs. 2017;84(3):319-342.CrossRef Zhou S, Niederdeppe J. The promises and pitfalls of personalization in narratives to promote social change. Communication Monographs. 2017;84(3):319-342.CrossRef
28.
Zurück zum Zitat Bhattacharyya OK, Estey EA, Zwarenstein M. Methodologies to evaluate the effectiveness of knowledge translation interventions: a primer for researchers and health care managers. Journal of Clinical Epidemiology. 2011;64(1):32-40.CrossRef Bhattacharyya OK, Estey EA, Zwarenstein M. Methodologies to evaluate the effectiveness of knowledge translation interventions: a primer for researchers and health care managers. Journal of Clinical Epidemiology. 2011;64(1):32-40.CrossRef
29.
Zurück zum Zitat Van Wijk R, Jansen JJ, Lyles MA. Inter‐and intra‐organizational knowledge transfer: a meta‐analytic review and assessment of its antecedents and consequences. Journal of Management Studies. 2008;45(4):830-853.CrossRef Van Wijk R, Jansen JJ, Lyles MA. Inter‐and intra‐organizational knowledge transfer: a meta‐analytic review and assessment of its antecedents and consequences. Journal of Management Studies. 2008;45(4):830-853.CrossRef
30.
Zurück zum Zitat Szott K. Contingencies of the will: Uses of harm reduction and the disease model of addiction among health care practitioners. Health:. 2015;19(5):507-522.CrossRef Szott K. Contingencies of the will: Uses of harm reduction and the disease model of addiction among health care practitioners. Health:. 2015;19(5):507-522.CrossRef
31.
Zurück zum Zitat White WL, Evans AC. The recovery agenda: The shared role of peers and professionals. Public Health Reviews. 2013;35(2):4.CrossRef White WL, Evans AC. The recovery agenda: The shared role of peers and professionals. Public Health Reviews. 2013;35(2):4.CrossRef
32.
Zurück zum Zitat Humphreys K, Lembke A. Recovery‐oriented policy and care systems in the UK and USA. Drug and Alcohol Review. 2014;33(1):13-18.CrossRef Humphreys K, Lembke A. Recovery‐oriented policy and care systems in the UK and USA. Drug and Alcohol Review. 2014;33(1):13-18.CrossRef
33.
Zurück zum Zitat White WL, Kelly JF, Roth JD. New addiction-recovery support institutions: Mobilizing support beyond professional addiction treatment and recovery mutual aid. Journal of Groups in Addiction & Recovery. 2012;7(2-4):297-317.CrossRef White WL, Kelly JF, Roth JD. New addiction-recovery support institutions: Mobilizing support beyond professional addiction treatment and recovery mutual aid. Journal of Groups in Addiction & Recovery. 2012;7(2-4):297-317.CrossRef
34.
Zurück zum Zitat Karan, Patel Sean, Bunachita Ank A, Agarwal Aaron, Lyon Urvish K, Patel Opioid Use Disorder: Treatments and Barriers. Cureus 10.7759/cureus.13173 Karan, Patel Sean, Bunachita Ank A, Agarwal Aaron, Lyon Urvish K, Patel Opioid Use Disorder: Treatments and Barriers. Cureus 10.7759/cureus.13173
35.
Zurück zum Zitat Muthén L, Muthén B. Statistical analysis with latent variables. New York: Wiley, 2009. Muthén L, Muthén B. Statistical analysis with latent variables. New York: Wiley, 2009.
Metadaten
Titel
Support for COVID-19-Related Substance Use Services Policy Changes: a New York State-Wide Survey
verfasst von
Amar D. Mandavia, MA
Aimee Campbell, PhD.
Brandy F. Henry, PhD.
Michael Chaple, PhD.
Timothy Hunt, PhD.
Caroline Arout, PhD.
Elwin Wu, PhD.
Harold A. Pincus, MD
Edward V. Nunes, MD
Pat Lincourt, MSW
Frances R. Levin, MD
Nabila El-Bassel, PhD.
Publikationsdatum
02.02.2022
Verlag
Springer US
Schlagwort
COVID-19
Erschienen in
The Journal of Behavioral Health Services & Research / Ausgabe 3/2022
Print ISSN: 1094-3412
Elektronische ISSN: 1556-3308
DOI
https://doi.org/10.1007/s11414-021-09784-y

Neu im Fachgebiet Psychiatrie

Ab sofort gelten die neuen Verordnungsausnahmen für Lipidsenker

Freie Fahrt für Lipidsenker? Das nicht, doch mit niedrigerem Schwellenwert fürs Infarktrisiko und neuen Indikationen hat der G-BA die Verordnungs-Handbremse ein gutes Stück weit gelockert.

ADHS-Kranke verlieren sieben Lebensjahre

  • 11.02.2025
  • ADHS
  • Nachrichten

Ein ADHS verkürzt die Lebenserwartung um rund sieben Jahre, bei Frauen sind es sogar fast neun Jahre. Ein Großteil der erhöhten Sterblichkeit lässt sich auf modifizierbare Risikofaktoren wie Alkohol, Rauchen und psychische Begleiterkrankungen zurückführen.

Lagerungsschwindel hält trotz Manöver an: Was steckt dahinter?

Ob sich ein benigner paroxysmaler Lagerungsschwindel erfolgreich behandeln lässt, könnte einem chinesischen Team zufolge auch von psychischen Faktoren abhängen.

Enorme Einschränkungen auch im zweiten Jahr mit Long COVID

Auch mehr als ein Jahr nach einer SARS-CoV-2-Infektion leidet die Mehrheit der Betroffenen, die ein Post-COVID-Syndrom (PCS) entwickelt haben, weiterhin unter eingeschränkter körperlicher Leistungsfähigkeit, Fatigue, kognitiven Beeinträchtigungen und einer reduzierten Lebensqualität. Dies belegt eine Langzeitstudie aus Baden-Württemberg.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.